Cardio-renal physiology/pathophysiology

Citations 221-230 of 277 total displayed.

Past content (since Jan 1999):

Scientific Contributions
Catecholamines Block 2-Hydroxyestradiol-Induced Antimitogenesis in Mesangial Cells

Lefteris C. Zacharia, Edwin K. Jackson, Delbert G. Gillespie, and Raghvendra K. Dubey
Hypertension 2002;39:854-859, doi:10.1161/01.HYP.0000014502.44988.39 [Abstract] [Full text]  

Scientific Contributions
Nitric Oxide, Anti-Inflammatory Drugs on Renal Prostaglandins and Cyclooxygenase-2

Masaru Miyataka, Kathryn A. Rich, Marylou Ingram, Tadahiko Yamamoto, and Richard J. Bing
Hypertension 2002;39:785-789, doi:10.1161/hy0302.105689 [Abstract] [Full text]  

Scientific Contributions
Angiotensinogen and Its Cleaved Derivatives Inhibit Angiogenesis

Jérôme Célérier, Amauri Cruz, Noël Lamandé, Jean-Marie Gasc, and Pierre Corvol
Hypertension 2002;39:224-228, doi:10.1161/hy0202.103441 [Abstract] [Full text]  

Scientific Contributions
Stimulation of Collagen Production by Transforming Growth Factor-ß₁ During Differentiation of Cardiac Fibroblasts to Myofibroblasts

Victor V. Petrov, Robert H. Fagard, and Paul J. Lijnen
Hypertension 2002;39:258-263, doi:10.1161/hy0202.103268 [Abstract] [Full text]  

Scientific Contributions
Vasopressin Increases Intracellular NO Concentration via Ca²⁺ Signaling in Inner Medullary Collecting Duct

Takefumi Mori, Jeffrey G. Dickhout, and Allen W. Cowley, Jr
Hypertension 2002;39:465-469, doi:10.1161/hy02t2.102908 [Abstract] [Full text]  

Scientific Contributions
Interaction of O₂^- and NO in the Thick Ascending Limb

Pablo A. Ortiz and Jeffrey L. Garvin
Hypertension 2002;39:591-596, doi:10.1161/hy0202.103287 [Abstract] [Full text]  

Scientific Contributions
Perindopril Alters Vascular Angiotensin-Converting Enzyme, AT₁ Receptor, and Nitric Oxide Synthase Expression in Patients With Coronary Heart Disease

Jia Long Zhuo, Frederick A.O. Mendelsohn, and Mitsuru Ohishi
Hypertension 2002;39:634-638, doi:10.1161/hy0202.103417 [Abstract] [Full text]  

Scientific Contributions
Renal Resistance Index and Progression of Renal Disease

Jörg Radermacher, Sebastian Ellis, and Hermann Haller
Hypertension 2002;39:699-703, doi:10.1161/hy0202.103782 [Abstract] [Full text]  

Hypertension Electronic Pages
Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100): Comparison With Enalapril

Juerg Nussberger, Grégoire Wuerzner, Chris Jensen, and Hans R. Brunner
Hypertension 2002;39: -8e, doi:10.1161/hy0102.102293 [Abstract] [Full text]  

Scientific Contributions
Cardiac and Renal Effects of Growth Hormone in Volume Overload–Induced Heart Failure: Role of NO

Ines Pagel, Thomas Langenickel, Klaus Höhnel, Sebastian Philipp, Andreas K. Nüssler, Werner F. Blum, Michel L. Aubert, Rainer Dietz, and Roland Willenbrock
Hypertension 2002;39:57-62, doi:10.1161/hy0102.098323 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28